Bill

Bill > HR5939


US HR5939

US HR5939
Triple-Negative Breast Cancer Research and Education Act of 2019


summary

Introduced
02/21/2020
In Committee
02/21/2020
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

To provide for research and education with respect to triple-negative breast cancer, and for other purposes. This bill requires research and education activities related to triple-negative breast cancer. (The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein.) The National Institutes of Health must conduct and support research into the disease, and the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop and disseminate information about triple-negative breast cancer for the public and for health care providers, respectively. Among other topics, the information must cover the elevated risk for minority women and the availability of a range of treatment options for such cancers.

AI Summary

This bill requires research and education activities related to triple-negative breast cancer. The National Institutes of Health must conduct and support research into the disease, while the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop and disseminate information about triple-negative breast cancer for the public and health care providers, respectively. The information must cover the elevated risk for minority women and the availability of treatment options. The bill also defines "minority women" as those belonging to a racial and ethnic minority group.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Referred to the House Committee on Energy and Commerce. (on 02/21/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...